In conditions such as rheumatoid arthritis, blockade of TNFα leads to a subsequent decrease in IL-1 and IL-6, adhesion molecules and angiogenic factors such as vascular endothelial growth factor (VEGF). This evidence concerns the gene IL6 and rheumatoid arthritis.